These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 9525881)
21. Evidence for a functional defect in the translocation of the methotrexate transport carrier in a methotrexate-resistant murine L1210 leukemia cell line. Schuetz JD; Matherly LH; Westin EH; Goldman ID J Biol Chem; 1988 Jul; 263(20):9840-7. PubMed ID: 2838483 [TBL] [Abstract][Full Text] [Related]
22. Folate transport and the modulation of antifolate sensitivity in a methotrexate-resistant human breast cancer cell line. Dixon KH; Trepel JB; Eng SC; Cowan KH Cancer Commun; 1991; 3(12):357-65. PubMed ID: 16296001 [TBL] [Abstract][Full Text] [Related]
23. Variable expression of RFC1 in human leukemia cell lines resistant to antifolates. Kobayashi H; Takemura Y; Ohnuma T Cancer Lett; 1998 Feb; 124(2):135-42. PubMed ID: 9500202 [TBL] [Abstract][Full Text] [Related]
24. Membrane transport of natural folates and antifolate compounds in murine L1210 leukemia cells: role of carrier- and receptor-mediated transport systems. Westerhof GR; Jansen G; van Emmerik N; Kathmann I; Rijksen G; Jackman AL; Schornagel JH Cancer Res; 1991 Oct; 51(20):5507-13. PubMed ID: 1655252 [TBL] [Abstract][Full Text] [Related]
25. A prominent low-pH methotrexate transport activity in human solid tumors: contribution to the preservation of methotrexate pharmacologic activity in HeLa cells lacking the reduced folate carrier. Zhao R; Gao F; Hanscom M; Goldman ID Clin Cancer Res; 2004 Jan; 10(2):718-27. PubMed ID: 14760095 [TBL] [Abstract][Full Text] [Related]
27. Role of the E45K-reduced folate carrier gene mutation in methotrexate resistance in human leukemia cells. Gifford AJ; Haber M; Witt TL; Whetstine JR; Taub JW; Matherly LH; Norris MD Leukemia; 2002 Dec; 16(12):2379-87. PubMed ID: 12454742 [TBL] [Abstract][Full Text] [Related]
28. Down-regulation of reduced folate carrier gene (RFC1) expression after exposure to methotrexate in ZR-75-1 breast cancer cells. Ma D; Huang H; Moscow JA Biochem Biophys Res Commun; 2000 Dec; 279(3):891-7. PubMed ID: 11162445 [TBL] [Abstract][Full Text] [Related]
29. Mutational analysis of the functional role of conserved arginine and lysine residues in transmembrane domains of the murine reduced folate carrier. Sharina IG; Zhao R; Wang Y; Babani S; Goldman ID Mol Pharmacol; 2001 May; 59(5):1022-8. PubMed ID: 11306683 [TBL] [Abstract][Full Text] [Related]
30. Chromosomal localization of the murine RFC-1 gene encoding a folate transporter and its amplification in an antifolate resistant variant overproducing the transporter. Roy K; Chiao JH; Spengler BA; Tolner B; Yang CH; Biedler JL; Sirotnak FM Cancer Genet Cytogenet; 1998 Aug; 105(1):29-38. PubMed ID: 9689927 [TBL] [Abstract][Full Text] [Related]
31. Decreased expression of the reduced folate carrier and folypolyglutamate synthetase is the basis for acquired resistance to the pemetrexed antifolate (LY231514) in an L1210 murine leukemia cell line. Wang Y; Zhao R; Goldman ID Biochem Pharmacol; 2003 Apr; 65(7):1163-70. PubMed ID: 12663051 [TBL] [Abstract][Full Text] [Related]
32. Expression of the reduced folate carrier SLC19A1 in IEC-6 cells results in two distinct transport activities. Rajgopal A; Sierra EE; Zhao R; Goldman ID Am J Physiol Cell Physiol; 2001 Nov; 281(5):C1579-86. PubMed ID: 11600421 [TBL] [Abstract][Full Text] [Related]
33. Concentrating capacity of the human reduced folate carrier (hRFC1) in human ZR-75 breast cancer cell lines. Sharif KA; Moscow JA; Goldman ID Biochem Pharmacol; 1998 May; 55(10):1683-9. PubMed ID: 9634005 [TBL] [Abstract][Full Text] [Related]
34. Loss of folic acid exporter function with markedly augmented folate accumulation in lipophilic antifolate-resistant mammalian cells. Assaraf YG; Goldman ID J Biol Chem; 1997 Jul; 272(28):17460-6. PubMed ID: 9211890 [TBL] [Abstract][Full Text] [Related]
36. Pattern of mutations that results in loss of reduced folate carrier function under antifolate selective pressure augmented by chemical mutagenesis. Zhao R; Sharina IG; Goldman ID Mol Pharmacol; 1999 Jul; 56(1):68-76. PubMed ID: 10385685 [TBL] [Abstract][Full Text] [Related]
37. Impaired membrane transport in methotrexate-resistant CCRF-CEM cells involves early translation termination and increased turnover of a mutant reduced folate carrier. Wong SC; Zhang L; Witt TL; Proefke SA; Bhushan A; Matherly LH J Biol Chem; 1999 Apr; 274(15):10388-94. PubMed ID: 10187828 [TBL] [Abstract][Full Text] [Related]
38. Comparison of methotrexate polyglutamylation in L1210 leukemia cells when influx is mediated by the reduced folate carrier or the folate receptor. Lack of evidence for influx route-specific effects. Spinella MJ; Brigle KE; Freemantle SJ; Sierra EE; Goldman ID Biochem Pharmacol; 1996 Sep; 52(5):703-12. PubMed ID: 8765468 [TBL] [Abstract][Full Text] [Related]
39. P-glycoprotein-mediated methotrexate resistance in CCRF-CEM sublines deficient in methotrexate accumulation due to a point mutation in the reduced folate carrier gene. Gifford AJ; Kavallaris M; Madafiglio J; Matherly LH; Stewart BW; Haber M; Norris MD Int J Cancer; 1998 Oct; 78(2):176-81. PubMed ID: 9754649 [TBL] [Abstract][Full Text] [Related]
40. Molecular events in the membrane transport of methotrexate in human CCRF-CEM leukemia cell lines. Freisheim JH; Ratnam M; McAlinden TP; Prasad KM; Williams FE; Westerhof GR; Schornagel JH; Jansen G Adv Enzyme Regul; 1992; 32():17-31. PubMed ID: 1323203 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]